913 related articles for article (PubMed ID: 33253192)
1. The Number Symbol Coding Task: A brief measure of executive function to detect dementia and cognitive impairment.
Galvin JE; Tolea MI; Moore C; Chrisphonte S
PLoS One; 2020; 15(11):e0242233. PubMed ID: 33253192
[TBL] [Abstract][Full Text] [Related]
2. Using a patient-reported outcome to improve detection of cognitive impairment and dementia: The patient version of the Quick Dementia Rating System (QDRS).
Galvin JE; Tolea MI; Chrisphonte S
PLoS One; 2020; 15(10):e0240422. PubMed ID: 33057404
[TBL] [Abstract][Full Text] [Related]
3. The Quick Physical Activity Rating (QPAR) scale: A brief assessment of physical activity in older adults with and without cognitive impairment.
Galvin JE; Tolea MI; Rosenfeld A; Chrisphonte S
PLoS One; 2020; 15(10):e0241641. PubMed ID: 33125429
[TBL] [Abstract][Full Text] [Related]
4. THE QUICK DEMENTIA RATING SYSTEM (QDRS): A RAPID DEMENTIA STAGING TOOL.
Galvin JE
Alzheimers Dement (Amst); 2015 Jun; 1(2):249-259. PubMed ID: 26140284
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Korean Quick Dementia Rating System (K-QDRS).
Ryu HJ; Moon Y; Kim M; Kim HJ; Galvin JE; Han SH
J Alzheimers Dis; 2021; 84(4):1645-1656. PubMed ID: 34719493
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Informant Quick Dementia Rating System (QDRS) among Older Adults in Singapore.
Pang T; Chong EJY; Wong ZX; Chew KA; Venketasubramanian N; Chen C; Xu X
J Alzheimers Dis; 2022; 89(4):1323-1330. PubMed ID: 36031899
[TBL] [Abstract][Full Text] [Related]
7. The Resilience Index: A Quantifiable Measure of Brain Health and Risk of Cognitive Impairment and Dementia.
Galvin JE; Kleiman MJ; Chrisphonte S; Cohen I; Disla S; Galvin CB; Greenfield KK; Moore C; Rawn S; Riccio ML; Rosenfeld A; Simon J; Walker M; Tolea MI
J Alzheimers Dis; 2021; 84(4):1729-1746. PubMed ID: 34744081
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
Liew TM; Feng L; Gao Q; Ng TP; Yap P
J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
[TBL] [Abstract][Full Text] [Related]
9. Using Optical Coherence Tomography to Screen for Cognitive Impairment and Dementia.
Galvin JE; Kleiman MJ; Walker M
J Alzheimers Dis; 2021; 84(2):723-736. PubMed ID: 34569948
[TBL] [Abstract][Full Text] [Related]
10. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H
Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909
[TBL] [Abstract][Full Text] [Related]
11. Telephone screening for mild cognitive impairment in hispanics using the Alzheimer's questionnaire.
Salazar R; Velez CE; Royall DR
Exp Aging Res; 2014; 40(2):129-39. PubMed ID: 24625043
[TBL] [Abstract][Full Text] [Related]
12. Staging of cognitive impairment in Parkinson's disease: validity of Quick Dementia Rating System.
Mahmoudi Asl A; Mehdizadeh M; Raeesi Roudbari P; Mehdizadeh H; Habibi SA; Niazi Khatoon J; Taghizadeh G
Disabil Rehabil; 2022 Jan; 44(1):44-51. PubMed ID: 32374182
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE.
Razavi M; Tolea MI; Margrett J; Martin P; Oakland A; Tscholl DW; Ghods S; Mina M; Galvin JE
Alzheimer Dis Assoc Disord; 2014; 28(2):156-61. PubMed ID: 24113559
[TBL] [Abstract][Full Text] [Related]
14. Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.
O'Caoimh R; Timmons S; Molloy DW
J Alzheimers Dis; 2016; 51(2):619-29. PubMed ID: 26890758
[TBL] [Abstract][Full Text] [Related]
15. Association between executive dysfunction and hippocampal volume in Alzheimer's disease.
Nagata T; Shinagawa S; Ochiai Y; Aoki R; Kasahara H; Nukariya K; Nakayama K
Int Psychogeriatr; 2011 Jun; 23(5):764-71. PubMed ID: 21106135
[TBL] [Abstract][Full Text] [Related]
16. [The feasibility of using Quick Dementia Rating System in clinical practice: results of a multi-center prospective validation study].
Levin OS; Vasenina EE; Sonin AG; Tayupova GN; Zatsepina OE; Ostapenko TN
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):40-47. PubMed ID: 30499495
[TBL] [Abstract][Full Text] [Related]
17. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
18. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
